ArticleGenes & diseases2026

GXYLT2 serves as a prognostic biomarker and is associated with β-catenin activation and gastric cancer aggressiveness.

Jiale Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.